Immunosuppression-driven HBV reactivation is characterized by HBsAg mutants with enhanced capability to escape immune response

V Svicher; R Salpini; C Alteri; M.C Bellocchi; L Colagrossi; D Armenia; M Aragri; F. Di Santo; L Carioti; F Continenza; A Bertoli; Y. Louzoun

Immunosuppression-driven HBV reactivation is characterized by HBsAg mutants with enhanced capability to escape immune response

V Svicher
, R Salpini
, C Alteri
, M.C Bellocchi
, L Colagrossi
, D Armenia
, M Aragri
, F. Di Santo
, L Carioti
, F Continenza
, A Bertoli
, Y. Louzoun

Department of Mathematics

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Antiviral Therapy
Volume	19
Issue number	2
State	Published - 2014

Bibliographical note

Conference: International Workshop on Antiviral Drug Resistance - Meeting the Global

Cite this

@article{5f77cc3f0e6f4b67942c58ce3f8d169b,

title = "Immunosuppression-driven HBV reactivation is characterized by HBsAg mutants with enhanced capability to escape immune response",

author = "V Svicher and R Salpini and C Alteri and M.C Bellocchi and L Colagrossi and D Armenia and M Aragri and \{Di Santo\}, F. and L Carioti and F Continenza and A Bertoli and Y. Louzoun",

note = "Conference: International Workshop on Antiviral Drug Resistance - Meeting the Global",

year = "2014",

language = "American English",

volume = "19",

journal = "Antiviral Therapy",

issn = "1359-6535",

publisher = "Sage Publications",

number = "2",

}

TY - JOUR

T1 - Immunosuppression-driven HBV reactivation is characterized by HBsAg mutants with enhanced capability to escape immune response

AU - Svicher, V

AU - Salpini, R

AU - Alteri, C

AU - Bellocchi, M.C

AU - Colagrossi, L

AU - Armenia, D

AU - Aragri, M

AU - Di Santo, F.

AU - Carioti, L

AU - Continenza, F

AU - Bertoli, A

AU - Louzoun, Y.

N1 - Conference: International Workshop on Antiviral Drug Resistance - Meeting the Global

PY - 2014

Y1 - 2014

UR - https://www.researchgate.net/publication/295583958_Immunosuppression-driven_HBV_reactivation_is_characterized_by_HBsAg_mutants_with_enhanced_capability_to_escape_immune_response

M3 - Article

SN - 1359-6535

VL - 19

JO - Antiviral Therapy

JF - Antiviral Therapy

IS - 2

ER -

Immunosuppression-driven HBV reactivation is characterized by HBsAg mutants with enhanced capability to escape immune response

Bibliographical note

Other files and links

Cite this